Industry News

Vimy Pharma: Company says product won’t be available in January, still aiming for 2026

October 16, 2025

As the race among drug makers heats up to deliver a generic form of the blockbuster drug Ozempic next year, Vimy Pharmaceuticals Inc., a new entrant to the field, is aiming to produce a made-inCanada version.

With measles elimination status in peril, country faces a wake-up call

October 16, 2025

Canadian health experts equipped with binders of information on the prolonged measles outbreak will travel in November to Mexico City, where an international committee will determine whether Canada maintains its elimination status for the disease.

Why Biotech’s Rally Can Last This Time

October 13, 2025

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another short-lived bounce.

Why ‘organ chips’ could transform cancer treatment and drug testing

October 11, 2025

Lab-made technology with living tissue could guide future drug development, scientists say.

RFK Jr. cancels $500M US in funding for vaccine development, targeting mRNA

August 5, 2025

The U.S. Department of Health and Human Services, helmed by Health and Human Services Secretary Robert F. Kennedy Jr., has pulled funding and cancelled contracts for vaccine development projects involving mRNA technology.

How a Trump-fueled brain drain could be the rest of the world’s brain gain

June 1, 2025

Months into President Donald Trump’s second term, as his administration wages an unprecedented war on the country’s top universities and research institutions,

World Scientists Look Elsewhere as U.S. Labs Stagger Under Trump Cuts

May 31, 2025

With the welcome mat withdrawn for promising researchers from around the world, America is at risk of losing its longstanding pre-eminence in the sciences.